BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 28019725)

  • 21. KCC3 loss-of-function contributes to Andermann syndrome by inducing activity-dependent neuromuscular junction defects.
    Bowerman M; Salsac C; Bernard V; Soulard C; Dionne A; Coque E; Benlefki S; Hince P; Dion PA; Butler-Browne G; Camu W; Bouchard JP; Delpire E; Rouleau GA; Raoul C; Scamps F
    Neurobiol Dis; 2017 Oct; 106():35-48. PubMed ID: 28647557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The bumetanide-sensitive Na-K-2Cl cotransporter NKCC1 as a potential target of a novel mechanism-based treatment strategy for neonatal seizures.
    Kahle KT; Staley KJ
    Neurosurg Focus; 2008 Sep; 25(3):E22. PubMed ID: 18759624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The K-Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosum.
    Howard HC; Mount DB; Rochefort D; Byun N; Dupré N; Lu J; Fan X; Song L; Rivière JB; Prévost C; Horst J; Simonati A; Lemcke B; Welch R; England R; Zhan FQ; Mercado A; Siesser WB; George AL; McDonald MP; Bouchard JP; Mathieu J; Delpire E; Rouleau GA
    Nat Genet; 2002 Nov; 32(3):384-92. PubMed ID: 12368912
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CIP1 is an activator of the K+-Cl- cotransporter KCC2.
    Wenz M; Hartmann AM; Friauf E; Nothwang HG
    Biochem Biophys Res Commun; 2009 Apr; 381(3):388-92. PubMed ID: 19232517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted disruption of the Wnk4 gene decreases phosphorylation of Na-Cl cotransporter, increases Na excretion and lowers blood pressure.
    Ohta A; Rai T; Yui N; Chiga M; Yang SS; Lin SH; Sohara E; Sasaki S; Uchida S
    Hum Mol Genet; 2009 Oct; 18(20):3978-86. PubMed ID: 19633012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Challenges of Finding Novel Drugs Targeting the K-Cl Cotransporter.
    Delpire E; Weaver CD
    ACS Chem Neurosci; 2016 Dec; 7(12):1624-1627. PubMed ID: 27998063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NH2-terminal heterogeneity in the KCC3 K+-Cl- cotransporter.
    Mercado A; Vázquez N; Song L; Cortés R; Enck AH; Welch R; Delpire E; Gamba G; Mount DB
    Am J Physiol Renal Physiol; 2005 Dec; 289(6):F1246-61. PubMed ID: 16048901
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCC3 axonopathy: neuropathological features in the central and peripheral nervous system.
    Auer RN; Laganière JL; Robitaille YO; Richardson J; Dion PA; Rouleau GA; Shekarabi M
    Mod Pathol; 2016 Sep; 29(9):962-76. PubMed ID: 27230413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential functional expression of cation-Cl- cotransporter mRNAs (KCC1, KCC2, and NKCC1) in rat trigeminal nervous system.
    Toyoda H; Yamada J; Ueno S; Okabe A; Kato H; Sato K; Hashimoto K; Fukuda A
    Brain Res Mol Brain Res; 2005 Jan; 133(1):12-8. PubMed ID: 15661361
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The chloride co-transporters, NKCC1 and KCC2, in experimental autoimmune encephalomyelitis (EAE).
    Yousuf MS; Zubkow K; Tenorio G; Kerr B
    Neuroscience; 2017 Mar; 344():178-186. PubMed ID: 28057537
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opposite effect of membrane raft perturbation on transport activity of KCC2 and NKCC1.
    Hartmann AM; Blaesse P; Kranz T; Wenz M; Schindler J; Kaila K; Friauf E; Nothwang HG
    J Neurochem; 2009 Oct; 111(2):321-31. PubMed ID: 19686239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deletion of KCC3 in parvalbumin neurons leads to locomotor deficit in a conditional mouse model of peripheral neuropathy associated with agenesis of the corpus callosum.
    Ding J; Delpire E
    Behav Brain Res; 2014 Nov; 274():128-36. PubMed ID: 25116249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of neuronal potassium/chloride cotransporter 3 (KCC3) is responsible for the degenerative phenotype in a conditional mouse model of hereditary motor and sensory neuropathy associated with agenesis of the corpus callosum.
    Shekarabi M; Moldrich RX; Rasheed S; Salin-Cantegrel A; Laganière J; Rochefort D; Hince P; Huot K; Gaudet R; Kurniawan N; Sotocinal SG; Ritchie J; Dion PA; Mogil JS; Richards LJ; Rouleau GA
    J Neurosci; 2012 Mar; 32(11):3865-76. PubMed ID: 22423107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression and regulation of the Na+-K+-2Cl- cotransporter NKCC1 in the normal and CFTR-deficient murine colon.
    Bachmann O; Wüchner K; Rossmann H; Leipziger J; Osikowska B; Colledge WH; Ratcliff R; Evans MJ; Gregor M; Seidler U
    J Physiol; 2003 Jun; 549(Pt 2):525-36. PubMed ID: 12692180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMSN/ACC truncation mutations disrupt brain-type creatine kinase-dependant activation of K+/Cl- co-transporter 3.
    Salin-Cantegrel A; Shekarabi M; Holbert S; Dion P; Rochefort D; Laganière J; Dacal S; Hince P; Karemera L; Gaspar C; Lapointe JY; Rouleau GA
    Hum Mol Genet; 2008 Sep; 17(17):2703-11. PubMed ID: 18566107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary salt intake regulates WNK3-SPAK-NKCC1 phosphorylation cascade in mouse aorta through angiotensin II.
    Zeniya M; Sohara E; Kita S; Iwamoto T; Susa K; Mori T; Oi K; Chiga M; Takahashi D; Yang SS; Lin SH; Rai T; Sasaki S; Uchida S
    Hypertension; 2013 Nov; 62(5):872-8. PubMed ID: 24019400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase D1 variant associated with human epilepsy and peripheral nerve hypermyelination.
    Omer S; Jin SC; Koumangoye R; Robert SM; Duran D; Nelson-Williams C; Huttner A; DiLuna M; Kahle KT; Delpire E
    Clin Genet; 2021 Aug; 100(2):176-186. PubMed ID: 33904160
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drosophila glia use a conserved cotransporter mechanism to regulate extracellular volume.
    Leiserson WM; Forbush B; Keshishian H
    Glia; 2011 Feb; 59(2):320-32. PubMed ID: 21125654
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel GABA-mediated corticotropin-releasing hormone secretory mechanism in the median eminence.
    Kakizawa K; Watanabe M; Mutoh H; Okawa Y; Yamashita M; Yanagawa Y; Itoi K; Suda T; Oki Y; Fukuda A
    Sci Adv; 2016 Aug; 2(8):e1501723. PubMed ID: 27540587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cation-chloride cotransporters NKCC1 and KCC2 as potential targets for novel antiepileptic and antiepileptogenic treatments.
    Löscher W; Puskarjov M; Kaila K
    Neuropharmacology; 2013 Jun; 69():62-74. PubMed ID: 22705273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.